Furthermore, the risk of kidney disease is higher in patients with metabolic syndrome27, which, if it is not strictly controlled in the subjects, will confound the relationship between NAFLD and RBP4. The gene discussed is RBP4; the disease is metabolic dysfunction-associated steatotic liver disease.